Marked suppression of tumor growth by FTY720 in a rat liver tumor model: the significance of down-regulation of cell survival Akt pathway.

We aim to investigate the anticancer effect of a novel immunomodulator FTY720 on a rat orthotopic liver tumor model. A buffalo rat orthotopic liver tumor model was established by injection of a buffalo hepatoma cell line MH7777 into the right portal vein. FTY720 was administered by intraperitoneal injection starting at 10 days after tumor cell injection at a dosage of 5 mg/kg/day. FTY720 markedly suppressed tumor growth and inhibited tumor progression by selective induction of apoptosis of tumor cells via down-regulation of phospho-Akt(ser473) and up-regulation of cleaved caspase-3, together with decrease of focal adhesion kinase. Moreover, the proliferation index of tumor cells was significantly reduced to 15.92+/-5.03% by FTY720 compared with that of 42.92+/-4.47% in the control group (p<0.001). In addition, we confirmed that FTY720 caused no effect on infiltrated lymphocyte in tumor tissue. We conclude that FTY720 is an effective anticancer agent for liver tumor in a rat model without affecting the immune system of the host.

[1]  K. Nan,et al.  Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma. , 2005, World journal of gastroenterology.

[2]  S. Fan,et al.  Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target. , 2005, Carcinogenesis.

[3]  G. Nicolson,et al.  Focal adhesion kinase regulates metastatic adhesion of carcinoma cells within liver sinusoids. , 2005, The American journal of pathology.

[4]  S. Fan,et al.  FTY720 Attenuates Hepatic Ischemia‐Reperfusion Injury in Normal and Cirrhotic Livers , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  S. Fan,et al.  FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation. , 2004, Carcinogenesis.

[6]  M. Matsuda,et al.  Decreased expression of CD28 coincides with the down‐modulation of CD3ζ and augmentation of caspase‐3 activity in T cells from hepatocellular carcinoma‐bearing patients and hepatitis C virus‐infected patients , 2004, Journal of gastroenterology and hepatology.

[7]  T. Fujii,et al.  Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. , 2004, Journal of hepatology.

[8]  Y. Maehara,et al.  Role of Expression of Focal Adhesion Kinase in Progression of Hepatocellular Carcinoma , 2004, Clinical Cancer Research.

[9]  S. Fan,et al.  Liver transplantation for hepatocellular carcinoma , 2004, The British journal of surgery.

[10]  S. Horie,et al.  Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment. , 2003, The Journal of urology.

[11]  M. Ikekita,et al.  A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells , 2003, British journal of pharmacology.

[12]  N. Forones,et al.  Apoptosis, PCNA and p53 in hepatocellular carcinoma. , 2002, Hepato-gastroenterology.

[13]  N. Nonomura,et al.  Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: Modulation of mitogenic signaling, FAK, cell‐cycle entry and apoptosis , 2002, International journal of cancer.

[14]  N. Ichimaru,et al.  Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. , 2002, Cancer research.

[15]  D. Yamamoto,et al.  FTY720, a novel immunosuppressive agent, induces apoptosis in human glioma cells. , 2001, Biochemical and biophysical research communications.

[16]  M. Iacocca,et al.  Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  S. Enosawa,et al.  Evidence that FTY720 induces T cell apoptosis in vivo. , 2000, Immunopharmacology.

[18]  J. Wong,et al.  Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. , 2000, Annals of surgery.

[19]  M. Kogire,et al.  Effect of a New Immunosuppressive Agent, Fty720, on Survival of Islet Allografts , 1998, Cell transplantation.

[20]  J. Bruix,et al.  Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution , 1998, Hepatology.

[21]  S. Kawai,et al.  A New Immunosuppressant, FTY720, Prolongs Limb Allograft Survival in Rats , 1998, Annals of plastic surgery.

[22]  S. Enosawa,et al.  Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720. , 1996, Immunopharmacology.

[23]  S. Enosawa,et al.  A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. , 1996, Transplantation.

[24]  W. Cance,et al.  Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. , 1995, Cancer research.

[25]  W. Cance,et al.  Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer , 2006, Annals of Surgical Oncology.

[26]  A. Cör,et al.  Proliferative and apoptotic activity in hepatocellular carcinoma and surrounding non-neoplastic liver tissue , 2001, Pflügers Archiv.